A feasibility study of perioperative administration of immunoenhancing enteral nutrients combined with pancrelipase in patients with pancreatoduodenectomy for pancreatic cancer
Not Applicable
Recruiting
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000027632
- Lead Sponsor
- agoya University, Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with active double cancer 2. Patients who have active infection 3. Patients who need to restrict food or water intake 4. Patients with milk or soy allergy 5. Patients with pancrelipase allergy 6. Patients with pork protein allergy 7. Patients with ileus 8. Patients with advanced liver dysfunction or advanced renal dysfunction 9. Patients with abnormal glucose metabolism, such as severe diabetes 10. Patients with congenital disorders of amino acid metabolism 11. Patients with pregnancy 12. Patients who were deemed inappropriate for medical reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment completion rate of preoperative ingestion of immunoenhancing enteral nutrients and pancrelipase
- Secondary Outcome Measures
Name Time Method